Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
09/2010
09/01/2010EP1979322B1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
09/01/2010EP1701945B1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN1939918B Production of midanping
09/01/2010CN101821238A Compounds which inhibit BETA-SECRETASE activity and methods of use thereof
09/01/2010CN101817823A Preparation method of 4,7-diazaindole and 5-site substitute thereof
09/01/2010CN101817811A 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
09/01/2010CN101817791A Method for directly producing water soluble aniline black
09/01/2010CN101817790A Ethylene diamine-modified elsinochrome A derivative and preparation method thereof
08/2010
08/31/2010US7786303 Acidic bath for electrolytically depositing a copper deposit containing halogenated or pseudohalogenated monomeric phenazinium compounds
08/31/2010US7786121 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
08/31/2010US7786115 Amide derivatives
08/26/2010WO2010096384A2 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands
08/26/2010WO2010096011A1 Cyclopropyl amide derivatives targeting the histamine h3 receptor
08/26/2010US20100216816 Pyrazinyl amide-t type calcium channel antagonists
08/26/2010US20100216815 N-substituted oxindoline derivatives as calcium channel blockers
08/26/2010US20100216812 Cyclopropyl Amide Derivatives
08/26/2010US20100216803 Ornithine derivative
08/26/2010US20100216770 Inhibitors of the Interaction Between MDM2 and P53
08/26/2010US20100216638 Herbicidally active bicyclic 1,3-dione compounds
08/26/2010US20100215620 The co-culture method of sphingomonas sp. bacterial strain and aspergillus sp. fungus strain, new anti-cancer and antibiotic glionitrins derived from this co-culture method, and pharmaceutical composition containing glionitrins or pharmaceutically acceptable salt thereof as an active ingredient
08/26/2010CA2752796A1 Cyclopropyl amide derivatives targeting the histamine h3 receptor
08/25/2010EP2220055A2 Novel heterocyclyl compounds and their use as chemokine antagonists
08/25/2010EP0883403B1 Method for treating sexual dysfunctions
08/25/2010CN1980909B Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
08/25/2010CN101812084A Rare earth metal amine compound containing aromatic amine methylene pyrrole ligand, preparation method and application thereof
08/25/2010CN101812027A Fluorescent pyrazine derivatives and methods of using the same in assessing renal function
08/25/2010CN101812026A Method for synthesizing bortezomib
08/25/2010CN101812025A Pyrazine aromatic acid ester compound, preparation method and medical application
08/25/2010CN101440067B Preparation of medicament intermediate 1-methyl-3-phenyl piperazine
08/25/2010CN101318938B Method for synthesizing quinoxaline derivant
08/24/2010US7781613 Inhibitor of hormone sensitive lipase; non-insulin dependent diabetes; antidiabetic agents; obesity
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010US20100210837 Pactamycin biosynthetic gene cluster
08/19/2010US20100210665 Diarylhydantoin compounds
08/19/2010US20100210635 Renin inhibitors
08/19/2010US20100210627 Pyrazine compounds, their use and methods of preparation
08/19/2010US20100210621 Crystalline polymorphic form 631
08/19/2010US20100210618 Piperidine/piperazine derivatives
08/19/2010US20100210474 Heterocyclic scaffolds useful for preparation of combinatorial libraries, libraries and methods for preparation thereof
08/18/2010CN101809003A Organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile and method for producing the same
08/18/2010CN101808995A Novel glucokinase activators and methods of using same
08/18/2010CN101808992A 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101805299A Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators
08/18/2010CN101805266A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/18/2010CN101182313B Chemical synthesis technique of quinoxaline
08/18/2010CN101007785B 2[(3-phenyl) acrylketone]-3-methylquinoxaline chemical synthesis method
08/17/2010US7777009 for modulation of chemokines; antiinflammatory agents; cancer
08/17/2010US7776860 Partial neutralization of the tri-hydrochloric acid salt directly results in the monohydrochloric acid salt and hydrates; serotonin receptor modulators having 5-HT1A-agonistic as well as 5-HT1D-antagonistic activity
08/12/2010WO2010090318A1 Coelenteramide analogs
08/12/2010WO2010089210A1 Novel herbicides
08/12/2010US20100204288 Heteroaryl-Ureas and Their Use as Glucokinase Activators
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204199 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
08/12/2010US20100203012 Iap bir domain binding compounds
08/12/2010CA2751440A1 Novel herbicides
08/11/2010EP2216329A1 Processes for the preparation of tadalafi
08/11/2010EP2215908A1 2-Alkyl-cycloalk(en)yl-carboxamides and their use as fungizides
08/11/2010EP2215076A2 Compounds that inhibit protease cathepsin s and hcv replication
08/11/2010EP2215055A1 New non-peptide derivatives as bradykinin b1 antagonists
08/11/2010EP2215052A1 Desferrioxamine conjugates, derivatives and analogues
08/11/2010CN101801938A non-basic melanin concentrating hormone receptor-1 antagonists and methods
08/11/2010CN101016268B Chemical synthesis method for 2-formylcyanoacetylhydrazone-quinoxaline-1,4-dioxide
08/11/2010CN101016267B Chemical synthesis method for 3-methylquinoxaline-2-carboxylic acid
08/11/2010CN101010305B Catalysis of diketopiperazine synthesis
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772240 used for the treatment of psychological disorders such as schizophrenia, anxiety, depression and bipolar disorder
08/10/2010US7772237 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
08/10/2010US7772225 N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
08/10/2010US7772190 E.g., isobutyl N-methyl-N-trimethylallophanoyl-L-alanyl-D-lactate; using parasiticides and nematocides in medicine and veterinary medicine; productive and breeding animals; foods and feeds
08/05/2010WO2010088450A2 Methods for treating diseases associated with the modulation of serca
08/05/2010WO2010087399A1 Urotensin-ii receptor antagonists
08/05/2010WO2010087117A1 Method for producing dichloropyrazine derivative
08/05/2010WO2010086177A1 Sulfamoyl- phenyl-ureido benzamidine-derivatives as antimalarial agents
08/05/2010WO2010085968A1 Toluidine sulfonamides and their use as hif-inhibitors
08/05/2010US20100197919 Method for producing macrolide compound and production intermediate thereof
08/05/2010US20100197696 Pesticidal heterocyclic dihaloallyl compounds
08/05/2010US20100197674 Oxopyrazine derivative and herbicide
08/05/2010US20100197640 Novel sulfamoyl-phenyl-ureido compounds and their use as medicament
08/05/2010US20100196460 Integrated Photoactive Agents for Real-Time Monitoring of Hemostasis
08/05/2010US20100193774 Quinoid Compounds and Their Use in Semiconducting Matrix Materials, Electronic and Optoelectronic Structural Elements
08/05/2010DE102009006643A1 Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten Preparation of halogenated N-heteroaromatic Polyhalogenderivaten
08/05/2010CA2750967A1 Sulfamoyl-phenyl-ureido benzamidine-derivatives as antimalarial agents
08/04/2010EP2213666A1 Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application
08/04/2010EP2213662A1 Azaindenofluorenedione derivative, organic electroluminescent device material, and organic electroluminescent device
08/04/2010EP2212310A2 An industrially feasible process for the manufacture of bisquinoline derivatives by using substantially pure n-monosubstituted piperazines
08/04/2010EP2212300A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators
08/04/2010EP2212299A1 Piperazinyl-sulfonamide derivatives useful in the treatment of gpr38 receptor mediated diseases
08/04/2010EP2212287A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE
08/04/2010CN1360502B Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders
08/04/2010CN101796033A Substituted piperazines as CB1 antagonists
08/04/2010CN101796032A Substituted piperazines as CB1 antagonists
08/04/2010CN101792420A Preparation of halogenated n-heteroaromatic polyhalogen derivatives
08/04/2010CN101531640B Preparation method of Quizalofop-p-ethyl with high optical content
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767684 N-acylsulfonamide derivatives; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; for example, N-(4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide
08/03/2010US7767683 Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament
08/03/2010US7767678 treating with hot water; pancreatic and prostate cancer
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 187